Browse by category

A Monell Chemical Senses Center study has identified that GLP-1 receptor agonists as a promising therapeutic for managing the metabolic...

Investigators from Mass General Brigham who examined claims data from nearly two million people between 2021 and 2023, have reported a...

Biolexis Therapeutics has achieved a transformative milestone in metabolic drug discovery with the successful resolution of the...

A research team from the School of Public Health, in the LKS Faculty of Medicine of the University of Hong Kong (HKUMed), who assessed...

The Centers for Medicare & Medicaid Services (CMS) formally approved a new quality measure developed by the Quality Team at North...

Jiangsu Hengrui Pharmaceuticals and Kailera Therapeutics have announced positive topline data from the 8mg dose of Hengrui Pharma’s Phase...

People with diabetes who were taking GLP-1 receptor agonist drugs such as tirzepatide and semaglutide had significantly lower rates of...

Over 93% of bariatric patients said they would undergo bariatric surgery again, compared with just over half of those who said they would...

More than half of US adults, an estimated that 137 million people, are eligible for semagludtide for weight loss, diabetes management, or...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may be associated with shrinking the human heart and other muscles, according to a...